Small Cell Lung Cancer: Discovering New Metabolic Pathways
2 Views
administrator
07/04/23
Learn More - bit.ly/2yQ29Jj
Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug therapies.
SCLC is a deadly and aggressive form of lung cancer with few therapeutic options and an incredibly low five-year survival rate of 5 percent. Researchers at CRI believe the key to finding new therapies for this disease lies in better understanding the metabolism of SCLC.
-
Category
Show more
Facebook Comments
No comments found